Insights

Innovative Product Focus Inbiose specializes in developing human milk oligosaccharides and specialty carbohydrates that are increasingly in demand within infant nutrition, cosmetics, and health sectors, presenting substantial opportunities for expansion into health-focused consumer markets.

Sustainable Manufacturing Utilizing cost-effective and sustainable fermentation processes for oligosaccharide production, Inbiose offers a compelling value proposition for customers seeking eco-friendly and scalable ingredient solutions, which enhances potential partnerships with brands committed to sustainability.

Strong Industry Collaborations With established collaborations with major players like DuPont and significant investment from the European Investment Bank, Inbiose demonstrates credibility and potential for rapid growth, opening doors for strategic alliances and larger distribution channels.

Growth Potential Despite current revenue levels below one million dollars, Inbiose's new product pipeline, ongoing research, and substantial funding position it for accelerated market penetration and sales opportunities across baby nutrition, supplement, and cosmetic markets.

Technological Edge Through advanced biotech development platforms including high-throughput screening and process scale-up capabilities, Inbiose can accelerate product development, enabling partners to bring innovative carbohydrate-based products to market faster, fostering competitive advantage.

Inbiose Tech Stack

Inbiose uses 8 technology products and services including Open Graph, NoSQL, Jupyter, and more. Explore Inbiose's tech stack below.

  • Open Graph
    Content Management System
  • NoSQL
    Database
  • Jupyter
    File Sharing
  • core-js
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Linux
    Programming Languages
  • Plyr
    Video Players
  • HTTP/3
    Web & Portal Technology

Inbiose's Email Address Formats

Inbiose uses at least 1 format(s):
Inbiose Email FormatsExamplePercentage
First.Last@inbiose.comJohn.Doe@inbiose.com
81%
Last@inbiose.comDoe@inbiose.com
10%
First.MiddleLast@inbiose.comJohn.MichaelDoe@inbiose.com
8%
First.Middle@inbiose.comJohn.Michael@inbiose.com
1%

Frequently Asked Questions

Where is Inbiose's headquarters located?

Minus sign iconPlus sign icon
Inbiose's main headquarters is located at Zwijnaarde, Flanders 9052 Belgium. The company has employees across 1 continents, including Europe.

What is Inbiose's official website and social media links?

Minus sign iconPlus sign icon
Inbiose's official website is inbiose.com and has social profiles on LinkedInCrunchbase.

What is Inbiose's SIC code NAICS code?

Minus sign iconPlus sign icon
Inbiose's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inbiose have currently?

Minus sign iconPlus sign icon
As of March 2026, Inbiose has approximately 56 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: D. A.Chief Financial Officer: B. F.Chief Operating Officer: J. S.. Explore Inbiose's employee directory with LeadIQ.

What industry does Inbiose belong to?

Minus sign iconPlus sign icon
Inbiose operates in the Biotechnology Research industry.

What technology does Inbiose use?

Minus sign iconPlus sign icon
Inbiose's tech stack includes Open GraphNoSQLJupytercore-jsSlider RevolutionLinuxPlyrHTTP/3.

What is Inbiose's email format?

Minus sign iconPlus sign icon
Inbiose's email format typically follows the pattern of First.Last@inbiose.com. Find more Inbiose email formats with LeadIQ.

How much funding has Inbiose raised to date?

Minus sign iconPlus sign icon
As of March 2026, Inbiose has raised $18M in funding. The last funding round occurred on Jul 14, 2021 for $18M.

When was Inbiose founded?

Minus sign iconPlus sign icon
Inbiose was founded in 2013.

Inbiose

Biotechnology ResearchFlanders, Belgium51-200 Employees

“Dedicated to specialty carbohydrates for human health and beyond”

Inbiose is dedicated to improving human health by making specialty oligosaccharides available for mainstream use. We strive to make available to the consumer the health benefits these complex sugars can bring to human and infant health, as well as specialized nutrition, cosmetics and beyond.

Inbiose is a leading company in the development of Human Milk Oligosaccharides, which are of paramount importance for the health of newborns and developing infants.

Our competences lie in the rapid development and cost-effective production of innovative specialty carbohydrates otherwise unavailable to society at large.

Our development pipeline allows us to offer a high-throughput development platform, as well as process development, scale-up and regulatory services that compressing new product development cycles and minimizes time to market.

Section iconCompany Overview

Headquarters
Zwijnaarde, Flanders 9052 Belgium
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.